Skip to content

LIVALO Pharma

Active Risk: not assessed
Limited partnershipfounded 2026incorporated this yearBerlarij 10, 2500 Lier, BelgiumKBO/BCE: BE 1037.047.586
Summary

LIVALO Pharma is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2026 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Overview

Activity
Other business support services
NACE 82990
1 site
Size
No accounts filed yet
Financial health
No score: no figuresToo young for a probability
Structure
Board
1 member
Signals- Young companyShow the evidence

Signals

1 signal. The signal on the left, the evidence on the right.
+raises risk
raises risk · Young company
Founded in 2026, under 3 years in business. Failure risk is statistically highest between 2 and 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 0 years 0 10 y
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. IncorporationAppointment: Godelieve Van Look (non-statutory…

Key points

  • Founded 5 months agofounded 20-04-2026 5 mo View
  • No annual accounts yetat the National Bank 0 View
  • One director decidessole director in office 1 View

By topic

Company details

Sites
1
Legal form
Limited partnership
Activity
Other business support servicesNACE 82990
Founded
20-04-2026
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
14
Financial year
From 1 July to 30 June
Annual meeting
Third Thursday of December at 18:00
Purpose
Alle activiteiten met betrekking tot de farmaceutische sector, met inbegrip van maar niet…
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.